<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 7 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page6.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=7">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 7 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 7</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=7"><img src="../thumb/7.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>4a / 2020-04


   Standard Editorial Notes


   1.  Product entries are:                       dren should only be contemplated after careful con sideration
     (a)  compiled independently of manufacturer but in a manner   of the benefit:risk ratio, and should no al ternative medicines
        which accurately reflects the contents of the official product   be available.
        literature, processed by the publisher, in a standard format.   6.  Active salt: In order to assist practical prescribing, MIMS
        Pharmaceutical companies who choose to have their prod-  monthly publishes the mass of the active ingredient as a salt
        ucts listed check their proofs regularly.  or other combination (if applicable) as if it is prescribed to the
     (b)  intended to be brief, concise and practical.  patient and not the actual mg or molar content of the active
     (c)  a reminder/alert to the doctor (i.e. they assume that, given   entity. Eg. Amlodipine mesylate will be prescribed as 5 mg Am-
        basic information/key words, the doctor will know what   lodipine. For accurate details on the mg or molar concentration
        action to take, or where to obtain fur ther information).  of the active substance the prescriber is referred to the MDR
                                                  or package insert of the branded product.
     (d)  arranged alphabetically by proprietary name within the
        applicable pharmacological classification sub section.   7.  Only registered indications for products are listed. Prescribers must
        Should the indications for any product make it relevant to   weigh the benefit against risk when using products "off label".
        more than one pharmacologi  cal classification the full MIMS   8.  Prices: MIMS reflects the single exit price inclusive of VAT in
        entry will appear under its most important pharmacological   line with pricing legislation (Government Notice, Gazette No
        head ing to which reference will be made in other sub-  26304 of 30 April 2004). Prices do not reflect interim price adjust-
        sections (e.g. CEPASCAMINE See sect. 1.8).  ments. Prices printing blue have been adjusted in line with the
     (e)  compiled making extensive use of abbreviations. Great care   2019 annual Department of Health SEP increase. Prescribers
                                                  are reminded that this price excludes any professional fees
        has been taken to ensure that no difficulty in understanding   that may be applicable and will not necessarily be what their
        the meaning of the ab breviations will be experienced. As   patients will pay.
        far as possi ble consistency in these abbreviations has been
        implemented.                            9.  When prescribing any product listed in MIMS, doctors should be
     (f)  not inclusive of inactive ingredients where applicable (e.g.   mindful of the important points appearing randomly throughout
                                                  the text. It should be noted that these aspects will not necessar-
        sugar/alcohol content, preservatives etc.). For detailed   ily appear in the product listing. Only where they are of clinical
        information please refer the current MDR where applicable,   significance to the product have they been included.
        the current package insert or the relevant pharmaceutical   10.  As MIMS is amended each month, only the current issue is
        company.                                  up-to-date. When in doubt or when full infor mation is required,
   2.  The extent of information will not be the same for all prod-  consult the current MDR where applicable, the current package
     ucts. This depends largely on the package insert. The C/I,    insert or the rele  vant pharmaceutical company. For any product
     S/E, S/P and D/I of old medicines not yet called up for registra-  not listed in MIMS, please consult the relevant package insert.
     tion may appear to be inconsistent in comparison to newly   11.  In certain cases and specific categories where in formation can-
     registered products with the same active ingredients. If C/I,   not be adequately summarised, cross-reference to full prescrib-
     S/E, S/P or D/I have not been specified it should not necessar-  ing information has been made by either a reference to MDR if
     ily be accepted that none apply. In cases where an applicant   the product is fully detailed, or otherwise to the manufacturer.
     has different products appearing in the same pharmacological   We have called such entries ‘product identification listings’
     clas sification and which contain the same active ingredient,   which give only the following: proprietary name, applicant,
     the safety aspects are only included under one listing and the   registration/reference number, ac tive ingredient, scheduling
     other listings cross-referenced.             status, presentation, in dications, strength, pack and price.
   3.  Pregnancy and breastfeeding have been listed un  der the   12.  MIMS is an index of information and reference, and not an assess-
     heading C/I where the product is known to be dangerous to   ment of the various preparations. Dependent on the participation
     the foetus during either pregnancy, labour or lactation. When   of pharmaceutical companies, MIMS has been made as complete
     included under S/P, this should alert the prescriber to a known   as possible in its product listings.
     risk of adverse reactions in these circumstances. In the ab-  13.  Every effort has been made to ensure the accura cy of the informa-
     sence of adequate studies in pregnant and lactating women,   tion published in this index. The publisher and their employees,
     all medicines carry a potential risk to the foetus and, if they are   agents or editors, however, cannot accept responsibili  ty for the
     ex  creted into milk, to the breastfed infant. The risk:benefit ratio   currency of the information or for any errors in copy or printing,
     must be established.                         omissions or for changes, etc., which may have occurred before,
   4.  Renal and/or liver dysfunction of any severity may in crease plas-  during or after publication, and shall, fur  thermore, not be liable
     ma concentrations and prolong the action of many medicines   under any circumstances whatever for any damages suffered
     eliminated mainly by these routes and may therefore increase   as a result of any such errors, omissions or changes.
     the risk of side-effects. Attention has been drawn to specific   14.  Unscheduled and schedule 1 and 2 medicines are only listed in
     products where toxicity is known to have occurred. Prescribers   MIMS, if they are:
     are reminded that caution is necessary when prescribing any   (1)  not advertised directly to consumers; or
     medicine to a patient with significantly impaired renal or liver   (2)  when they are advertised in consumer media, but generate
     function.                                      more than 10 000 scripts p.a. (Source NDTI)
   5.  Children: Where dosage recommendations for any product    15.  Details of recent market introductions are given in the Product
     are not specified for children, prescribers should be aware   News section. The editorial content is compiled from copy sup-
     that this may indicate that safety and efficacy have not been   plied by the companies con  cerned. The editors and publishers
     formally established in children, although there may be some   however, cannot accept any responsibility for the contents or
     clinical ex  perience in this age group. Administration to chil-  opin ions expressed therein.
                     MIMS subscription call centre office hours are from
                                 Monday to Friday 08:00-16:00
                Please feel free to contact: Riëtte (011) 280-5856; Sean (011) 280-5533</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page6.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page2.html">2</a>&nbsp;&nbsp;&nbsp;<a href="page3.html">3</a>&nbsp;&nbsp;&nbsp;<a href="page4.html">4</a>&nbsp;&nbsp;&nbsp;<a href="page5.html">5</a>&nbsp;&nbsp;&nbsp;<a href="page6.html">6</a>&nbsp;&nbsp;&nbsp;<a href="page7.html">7</a>&nbsp;&nbsp;&nbsp;<a href="page8.html">8</a>&nbsp;&nbsp;&nbsp;<a href="page9.html">9</a>&nbsp;&nbsp;&nbsp;<a href="page10.html">10</a>&nbsp;&nbsp;&nbsp;<a href="page11.html">11</a>&nbsp;&nbsp;&nbsp;<a href="page12.html">12</a>
             </td>
             <td width="35%"><a href="page8.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page8.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
